Terms and Conditions of Use Policy

About This Site Terms and Conditions of Use Policy Welcome Welcome to David D. Richardson, MD, Inc.’s website. The following Terms and Conditions govern your use of New-Glaucoma-Treatments.com site, and any content made available from or through this web site,...

How Does Canaloplasty Compare to Other Glaucoma Treatments?

How does Canaloplasty compare to other glaucoma treatments in terms of IOP Lowering benefits and average medication?  Here’s a summary from Dr. Douglas J. Rhee’s talk given on April 13, 2018 during the ASCRS 2018 Glaucoma Day “Is Trabeculectomy...

Glaucoma News Roundup 2017

Top Glaucoma News and Researches of 2017 Here’s a roundup of news, discoveries and research updates about glaucoma in 2017. Subscribe to our Newsletter (found on the right sidebar) or Follow us on Facebook to continue getting updates.   Latest news on Glaucoma...

Hydrus™ Microstent 2-Year Results

08.16.2018 NEWS UPDATE: Hydrus microstent wins FDA approval. The FDA has approved the use of the Hydrus microstent in conjunction with cataract surgery to reduce IOP in patients with mild to moderate primary open-angle glaucoma. Source: https://bit.ly/2MX19sM There...

Currently Available Methods to Treat Open Angle Glaucoma

Part 1 of 14 of “Adjusting the Faucet or Opening the Drain – Currently Available Methods to Treat the Plumbing Problem of Open Angle Glaucoma” | A San Gabriel Valley Optometric Society (SGVOS) Continuing Education Dinner Event – 2 hours CE | Featured...

Pin It on Pinterest